GILT restricts the cellular entry mediated by the envelope glycoproteins of SARS-CoV, Ebola virus and Lassa fever virus

References

• Hilgenfeld R, Peiris M. From SARS to MERS: 10 years of research on highly pathogenic human coronaviruses. Antiviral Res. 2013 Oct;100(1):286–295. doi: 10.1016/j.antiviral.2013.08.015
   PubMed Web of Science ®Google Scholar
• Andersen KG, Shapiro BJ, Matranga CB, et al. Clinical sequencing uncovers origins and evolution of Lassa virus. Cell. 2015 Aug 13;162(4):738–750. doi: 10.1016/j.cell.2015.07.020
   PubMed Web of Science ®Google Scholar
• Scott JT, Semple MG. Ebola virus disease sequelae: a challenge that is not going away. Lancet Infect Dis. 2017 May;17(5):470–471. doi: 10.1016/S1473-3099(17)30027-0
   PubMed Web of Science ®Google Scholar
• WHO. Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003. Geneva: WHO; 2014.
   Google Scholar
• Ebola Outbreak Epidemiology T. Outbreak of Ebola virus disease in the democratic republic of the Congo, April–May, 2018: an epidemiological study. Lancet. 2018 Jul 21;392(10143):213–221. doi: 10.1016/S0140-6736(18)31387-4
   PubMed Web of Science ®Google Scholar
• Attinsounon CA, Ossibi Ibara BR, Alassani A, et al. Report of a fatal case of Lassa fever in Parakou in 2018: clinical, therapeutic and diagnostic aspects. BMC Infect Dis. 2018 Dec 17;18(1):667. doi: 10.1186/s12879-018-3587-6
   PubMed Web of Science ®Google Scholar
• Schneider WM, Chevillotte MD, Rice CM. Interferon-stimulated genes: a complex web of host defenses. Annu Rev Immunol. 2014;32:513–545. doi: 10.1146/annurev-immunol-032713-120231
   PubMed Web of Science ®Google Scholar
• Brass AL, Huang IC, Benita Y, et al. The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus. Cell. 2009 Dec 24;139(7):1243–1254. doi: 10.1016/j.cell.2009.12.017
   PubMed Web of Science ®Google Scholar
• Liu SY, Aliyari R, Chikere K, et al. Interferon-inducible cholesterol-25-hydroxylase broadly inhibits viral entry by production of 25-hydroxycholesterol. Immunity. 2013 Jan 24;38(1):92–105. doi: 10.1016/j.immuni.2012.11.005
   PubMed Web of Science ®Google Scholar
• Shu Q, Lennemann NJ, Sarkar SN, et al. ADAP2 is an interferon stimulated gene that restricts RNA virus entry. Plos Pathog. 2015 Sep;11(9):e1005150. doi: 10.1371/journal.ppat.1005150
   PubMed Web of Science ®Google Scholar
• Doyle T, Moncorge O, Bonaventure B, et al. The interferon-inducible isoform of NCOA7 inhibits endosome-mediated viral entry. Nat Microbiol. 2018 Dec;3(12):1369–1376. doi: 10.1038/s41564-018-0273-9
   PubMed Web of Science ®Google Scholar
• Jiang D, Weidner JM, Qing M, et al. Identification of five interferon-induced cellular proteins that inhibit west Nile virus and dengue virus infections. J Virol. 2010 Aug;84(16):8332–8341. doi: 10.1128/JVI.02199-09
   PubMed Web of Science ®Google Scholar
• Weidner JM, Jiang D, Pan XB, et al. Interferon-induced cell membrane proteins, IFITM3 and tetherin, inhibit vesicular stomatitis virus infection via distinct mechanisms. J Virol. 2010 Dec;84(24):12646–12657. doi: 10.1128/JVI.01328-10
   PubMed Web of Science ®Google Scholar
• Zhao X, Li J, Winkler CA, et al. IFITM genes, variants, and their roles in the control and pathogenesis of viral infections. Front Microbiol. 2018;9:3228. doi: 10.3389/fmicb.2018.03228
   PubMed Web of Science ®Google Scholar
• Luster AD, Weinshank RL, Feinman R, et al. Molecular and biochemical characterization of a novel gamma-interferon-inducible protein. J Biol Chem. 1988 Aug 25;263(24):12036–12043.
   PubMed Web of Science ®Google Scholar
• Arunachalam B, Phan UT, Geuze HJ, et al. Enzymatic reduction of disulfide bonds in lysosomes: characterization of a gamma-interferon-inducible lysosomal thiol reductase (GILT). Proc Natl Acad Sci USA. 2000 Jan 18;97(2):745–750. doi: 10.1073/pnas.97.2.745
   PubMed Web of Science ®Google Scholar
• Maric M, Arunachalam B, Phan UT, et al. Defective antigen processing in GILT-free mice. Science. 2001 Nov 9;294(5545):1361–1365. doi: 10.1126/science.1065500
   PubMed Web of Science ®Google Scholar
• Phipps-Yonas H, Semik V, Hastings KT. GILT expression in B cells diminishes cathepsin S steady-state protein expression and activity. Eur J Immunol. 2013 Jan;43(1):65–74. doi: 10.1002/eji.201242379
   PubMed Web of Science ®Google Scholar
• Bogunovic B, Stojakovic M, Chen L, et al. An unexpected functional link between lysosomal thiol reductase and mitochondrial manganese superoxide dismutase. J Biol Chem. 2008 Apr 4;283(14):8855–8862. doi: 10.1074/jbc.M708998200
   PubMed Web of Science ®Google Scholar
• Chiang HS, Maric M. Lysosomal thiol reductase negatively regulates autophagy by altering glutathione synthesis and oxidation. Free Radic Biol Med. 2011 Aug 1;51(3):688–699. doi: 10.1016/j.freeradbiomed.2011.05.015
   PubMed Web of Science ®Google Scholar
• Teramoto T, Chiang HS, Takhampunya R, et al. Gamma interferon-inducible lysosomal thioreductase (GILT) ablation renders mouse fibroblasts sensitive to dengue virus replication. Virology. 2013 Jul 5;441(2):146–151. doi: 10.1016/j.virol.2013.03.017
   PubMed Web of Science ®Google Scholar
• Singh R, Cresswell P. Defective cross-presentation of viral antigens in GILT-free mice. Science. 2010 Jun 11;328(5984):1394–1398. doi: 10.1126/science.1189176
   PubMed Web of Science ®Google Scholar
• Hastings KT, Lackman RL, Cresswell P. Functional requirements for the lysosomal thiol reductase GILT in MHC class II-restricted antigen processing. J Immunol. 2006 Dec 15;177(12):8569–8577. doi: 10.4049/jimmunol.177.12.8569
   PubMed Web of Science ®Google Scholar
• Hastings KT. GILT: Shaping the MHC Class II-restricted Peptidome and CD4(+) T cell-mediated immunity. Front Immunol. 2013 Dec 4;4:429. doi: 10.3389/fimmu.2013.00429
   PubMed Web of Science ®Google Scholar
• Perreira JM, Chin CR, Feeley EM, et al. IFITMs restrict the replication of multiple pathogenic viruses. J Mol Biol. 2013 Dec 13;425(24):4937–4955. doi: 10.1016/j.jmb.2013.09.024
   PubMed Web of Science ®Google Scholar
• Mingo RM, Simmons JA, Shoemaker CJ, et al. Ebola virus and severe acute respiratory syndrome coronavirus display late cell entry kinetics: evidence that transport to NPC1+ endolysosomes is a rate-defining step. J Virol. 2015 Mar;89(5):2931–2943. doi: 10.1128/JVI.03398-14
   PubMed Web of Science ®Google Scholar
• West LC, Cresswell P. Expanding roles for GILT in immunity. Curr Opin Immunol. 2013 Feb;25(1):103–108. doi: 10.1016/j.coi.2012.11.006
   PubMed Web of Science ®Google Scholar
• Wang H, Shi Y, Song J, et al. Ebola viral glycoprotein bound to its endosomal receptor Niemann-Pick C1. Cell. 2016 Jan 14;164(1–2):258–268. doi: 10.1016/j.cell.2015.12.044
   PubMed Web of Science ®Google Scholar
• Carette JE, Raaben M, Wong AC, et al. Ebola virus entry requires the cholesterol transporter Niemann-Pick C1. Nature. 2011 Aug 24;477(7364):340–343. doi: 10.1038/nature10348
   PubMed Web of Science ®Google Scholar
• Simmons JA, D'Souza RS, Ruas M, et al. Ebolavirus glycoprotein directs fusion through NPC1+ endolysosomes. J Virol. 2016 Jan 1;90(1):605–610. doi: 10.1128/JVI.01828-15
   PubMed Web of Science ®Google Scholar
• Jiang D, Guo H, Xu C, et al. Identification of three interferon-inducible cellular enzymes that inhibit the replication of hepatitis C virus. J Virol. 2008 Feb;82(4):1665–1678. doi: 10.1128/JVI.02113-07
   PubMed Web of Science ®Google Scholar
• Zhao X, Sehgal M, Hou Z, et al. Identification of residues controlling restriction versus Enhancing activities of IFITM proteins on entry of human coronaviruses. J Virol. 2018 Mar 15;92(6):e01535–17. http://doi.org/10.1128/JVI.01535-17 doi: 10.1128/JVI.01966-17
   PubMed Web of Science ®Google Scholar
• Bulli L, Apolonia L, Kutzner J, et al. Complex Interplay between HIV-1 Capsid and MX2-independent alpha interferon-induced antiviral factors. J Virol. 2016 Aug 15;90(16):7469–7480. doi: 10.1128/JVI.00458-16
   PubMed Web of Science ®Google Scholar
• Zhao X, Guo F, Comunale MA, et al. Inhibition of endoplasmic reticulum-resident glucosidases impairs severe acute respiratory syndrome coronavirus and human coronavirus NL63 spike protein-mediated entry by altering the glycan processing of angiotensin I-converting enzyme 2. Antimicrob Agents Chemother. 2015 Jan;59(1):206–216. doi: 10.1128/AAC.03999-14
   PubMed Web of Science ®Google Scholar
• Zhao X, Guo F, Liu F, et al. Interferon induction of IFITM proteins promotes infection by human coronavirus OC43. Proc Natl Acad Sci USA. 2014 May 6;111(18):6756–6761. doi: 10.1073/pnas.1320856111
   PubMed Web of Science ®Google Scholar
• Cavrois M, De Noronha C, Greene WC. A sensitive and specific enzyme-based assay detecting HIV-1 virion fusion in primary T lymphocytes. Nat Biotechnol. 2002 Nov;20(11):1151–1154. doi: 10.1038/nbt745
   PubMed Web of Science ®Google Scholar
• Sealy R, Chaka W, Surman S, et al. Target peptide sequence within infectious human immunodeficiency virus type 1 does not ensure envelope-specific T-helper cell reactivation: influences of cysteine protease and gamma interferon-induced thiol reductase activities. Clin Vaccine Immunol. 2008 Apr;15(4):713–719. doi: 10.1128/CVI.00412-07
   PubMedGoogle Scholar
• Rausch MP, Hastings KT. Diverse cellular and organismal functions of the lysosomal thiol reductase GILT. Mol Immunol. 2015 Dec;68(2 Pt A):124–128. doi: 10.1016/j.molimm.2015.06.008
   PubMed Web of Science ®Google Scholar
• Li S, Sun Z, Pryce R, et al. Acidic pH-induced conformations and LAMP1 binding of the Lassa virus glycoprotein spike. Plos Pathog. 2016 Feb;12(2):e1005418. doi: 10.1371/journal.ppat.1005418
   PubMed Web of Science ®Google Scholar
• Cohen-Dvashi H, Israeli H, Shani O, et al. Role of LAMP1 binding and pH sensing by the spike complex of Lassa virus. J Virol. 2016 Nov 15;90(22):10329–10338. doi: 10.1128/JVI.01624-16
   PubMed Web of Science ®Google Scholar
• Lackman RL, Cresswell P. Exposure of the promonocytic cell line THP-1 to Escherichia coli induces IFN-gamma-inducible lysosomal thiol reductase expression by inflammatory cytokines. J Immunol. 2006 Oct 1;177(7):4833–4840. doi: 10.4049/jimmunol.177.7.4833
   PubMed Web of Science ®Google Scholar
• Chandran K, Sullivan NJ, Felbor U, et al. Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection. Science. 2005 Jun 10;308(5728):1643–1645. doi: 10.1126/science.1110656
   PubMed Web of Science ®Google Scholar
• Huang IC, Bosch BJ, Li F, et al. SARS coronavirus, but not human coronavirus NL63, utilizes cathepsin L to infect ACE2-expressing cells. J Biol Chem. 2006 Feb 10;281(6):3198–3203. doi: 10.1074/jbc.M508381200
   PubMed Web of Science ®Google Scholar
• Misasi J, Chandran K, Yang JY, et al. Filoviruses require endosomal cysteine proteases for entry but exhibit distinct protease preferences. J Virol. 2012 Mar;86(6):3284–3292. doi: 10.1128/JVI.06346-11
   PubMed Web of Science ®Google Scholar
• Huang IC, Bailey CC, Weyer JL, et al. Distinct patterns of IFITM-mediated restriction of filoviruses, SARS coronavirus, and influenza A virus. Plos Pathog. 2011 Jan 6;7(1):e1001258. doi: 10.1371/journal.ppat.1001258
   PubMed Web of Science ®Google Scholar
• Singh R, Jamieson A, Cresswell P. GILT is a critical host factor for Listeria monocytogenes infection. Nature. 2008 Oct 30;455(7217):1244–1247. doi: 10.1038/nature07344
   PubMed Web of Science ®Google Scholar
• Kubo Y, Izumida M, Yashima Y, et al. Gamma-interferon-inducible, lysosome/endosome-localized thiolreductase, GILT, has anti-retroviral activity and its expression is counteracted by HIV-1. Oncotarget. 2016 Nov 1;7(44):71255–71273. doi: 10.18632/oncotarget.12104
   PubMedGoogle Scholar
• Miyauchi K, Kim Y, Latinovic O, et al. HIV enters cells via endocytosis and dynamin-dependent fusion with endosomes. Cell. 2009 May 1;137(3):433–444. doi: 10.1016/j.cell.2009.02.046
   PubMed Web of Science ®Google Scholar